Acumen Pharmaceuticals

ABOSNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$15.384 M

$0.21 -1.66%

Close of 6 Nov 2026

As of 6 Nov 2026, Acumen Pharmaceuticals (ABOS) has a market capitalization of $15.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$121.3M

Loss-making

Shares outstanding

72,327,320

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#141PluriPLUR$17.1M
#142Jasper TherapeuticsJSPR$15.6M
#143Acumen PharmaceuticalsABOS$15.4M
#144Atyr PharmaATYR$15.4M
#145ScilexSCLX$14.3M

What if Acumen Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$390,403.98

Per share 1,835,468× higher

Bitcoin $1.53T

$21,124.08

Per share 99,314× higher

Apple $5.02T

$69,348.38

Per share 326,038× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Acumen Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.